Genedrive PLC (LSE:GDR) - Share price - Overview

Stock Report

Genedrive PLC GDR

Last Price
GBX33.50

Day Change
-1.50|-4.29%

As of 15/12/2017
14:39:53 GMT | GBX
Minimum 15 Minutes Delay.

Last Close35.00p
Day Range31.53 - 33.00
Mkt Cap6.26Mil
52-Wk Range30.00 - 60.00
Yield %0.00
ISINGB00B1VKB244
Volume8,828
P/E-1.52
P/S1.07
P/CF-3.39

Share Price

Total Returns 15/12/2017

 Chg (%)  
More ...
Genedrive PLC-10.67 
FTSE 100 TR GBP1.92
 
Financials
201520162017
More ...
Income Statement
Turnover4.525.065.79
Operating Profit-4.04-5.43-7.29
Net Profit-3.03-5.92-6.44
Reported EPS-30.20-56.20-34.90
Balance Sheet
Current Assets7.974.878.44
Non Current Assets8.036.993.61
Total Assets15.9911.8612.05
Current Liabilities2.421.862.16
Total Liabilities6.458.108.61
Total Equity9.553.753.44
Cash Flow
Operating Cash Flow-4.82-4.19-2.60
Net Change in Cash0.40-4.014.13
Broker Forecasts
Year EndingPre-taxEPSEPSgP/EPEGDPSYld %
More ...
'Broker Forecasts' provides consensus figures based on several brokers' views
2018-5.87-11.18--3.00---
2019-4.22-15.70--2.13---
Director Dealings
TradedActionNotifierPriceAmountValue
More ...
17/02/2017PurchaseDr. Ian Gilham40.0062,50025,000.00

Company Profile

Genedrive PLC is a holding company engaged in molecular diagnostics business. The company is organised into operating divisions – Preclinical Research Services, Pharmacogenomic Services, and Diagnostics.

Sector

Diagnostics & Research

Market Position

1602 of 1835 Companies

Index

FTSE AIM All Share

Outlook

(06/11/2017) ch - "We look forward to updating investors during the year on further progress and delivery against our strategic objectives"

Next Event 30/03/2018

Next interim announcement
Ratios
CompSecMkt
More ...
PER (E)-2.5313.3516.21
Div Yld (E)0.004.164.22
PEG (E)0.0012.161.67
ROCE-85.75177.0416.28
Op Mrgn-83.72-9.451.34
EPS Grwth0.008.6210.82
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00

Broker Sentiment

Strong Buy0
Buy1
Hold0
Sell0
Strong Sell0
  • Strong Sell
  • Strong Buy
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
More ...
Disclaimer
Directors
More ...
ChairmanDr. Ian Gilham
Chief Executive OfficerDavid Budd
Chief Financial Officer & Company SecretMatthew Fowler
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2017 Morningstar. All rights reserved.